Evidence map›Paper›PMID 30324718›Full record

ArticleJournal of cellular and molecular medicine2018

CircRUNX2 through has-miR-203 regulates RUNX2 to prevent osteoporosis.

Qudong Yin, Jian Wang, Qiang Fu, Sanjun Gu, Yongjuan Rui

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Circular RNAs: Promising Targets in Osteoporosis.Current osteoporosis reports · 2023
    Review
  8. Review
  9. Article
  10. Review
  11. MicroRNA-loaded biomaterials for osteogenesis.Frontiers in bioengineering and biotechnology · 2022
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Recent advances in the epigenetics of bone metabolism.Journal of bone and mineral metabolism · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Qudong YinDepartment of Orthopaedics, Wuxi No. 9 People's Hospital Affiliated to Soochow University, Wuxi, Jiangsu, China.
Jian WangDepartment of Orthopaedics, Wuxi No. 9 People's Hospital Affiliated to Soochow University, Wuxi, Jiangsu, China.
Qiang FuDepartment of Laboratory, Jiangsu Institute of Parasitic Disease, Wuxi, Jiangsu, China.
Sanjun GuDepartment of Orthopaedics, Wuxi No. 9 People's Hospital Affiliated to Soochow University, Wuxi, Jiangsu, China.
Yongjuan RuiDepartment of Orthopaedics, Wuxi No. 9 People's Hospital Affiliated to Soochow University, Wuxi, Jiangsu, China.ORCID 0000-0002-4838-1805
Soochow University · CNJiangsu Institute of Parasitic Diseases · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe aimed to discover the molecular mechanism of hsa_circ_0076694 (circRUNX2) on osteogenic differentiation. We also explored the interaction between circRUNX2, miR-203 and RUNX2.

methodsClinical samples obtained from femoral neck fracture patients' bone tissues were used to collect circRUNX2, miR-203, and RUNX2 expression data, while their expression changes were observed in human bone mesenchymal stem cells (hBMSCs) during osteogenic differentiation. QRT-PCR and Western blot were used to analyse levels of RNAs and proteins. Biotin pull down, RIP, RNA FISH, and Dual-Luciferase Reporter assays demonstrated the relationship between circRUNX2, miR-203, and RUNX2. ALP and ARS staining were used to measure the degree of osteogenic differentiation under the control of circRUNX2, miR-203.

resultsCircRUNX2 were down-regulated in osteoporotic patients' bone tissues. CircRUNX2 could inhibit miR-203 expression by sponging miR-203. MiR-203 inhibited osteogenic differentiation by targeting the 3'-UTR of RUNX2 and down-regulate RUNX2 expression. Overexpression of circRUNX2 promoted the expression of osteogenic differentiation-related proteins such as RUNX2, OCN, OPN, BSP, and prevented osteoporosis.

conclusioncircRUNX2 could sponge miR-203 and enhance RUNX2 expression, thus circRUNX2 prevents osteoporosis and may provide a novel therapeutic strategy for it.

Indexed as

Bone Marrow CellsCell DifferentiationCell-Free Nucleic AcidsCore Binding Factor Alpha 1 SubunitGene Expression RegulationHumansMesenchymal Stem CellsMicroRNAsOsteoblastsOsteogenesisOsteoporosisRNA, Long NoncodingCell-Free Nucleic AcidsCore Binding Factor Alpha 1 SubunitMicroRNAsMIRN203 microRNA, humanRNA, Long NoncodingRUNX2 protein, humancircRUNX2MiR-203osteoporosisRUNX2

Identifiers

PMID30324718
PMCPMC6237596
OpenAlexW2897697037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.